As there is sexual dimorphism in the regulation of vascular tone, the aim of this present study was to determine whether there are sex differences in perivascular adipose tissue (PVAT)-mediated regulation of the porcine coronary artery (PCA) tone.
Introduction
Adipose tissue has traditionally been described as being simply a structural support, with additional lipid storage (white adipose tissue) and thermoregulator (brown adipose tissue) roles (Cannon and Nedergaard, 2004; Mariman and Wang, 2010) . However, compelling evidence in recent years has led to the view that adipose tissue is in fact an active secretory organ, which releases several bioactive signalling molecules, collectively termed adipokines, that are important in both health and disease (Fortuno et al., 2003; Havel, 2004; Thalmann and Meier, 2007; Yamawaki et al., 2010) . Numerous studies have established that there are variations in the function of adipose tissue in different sexes where, for instance, women have higher circulating adiponectin levels compared with men (Nishizawa et al., 2002; Cnop et al., 2003; Arita et al., 2012) .
Perivascular adipose tissue (PVAT) is positioned around the blood vessel and is regarded as being distinct from the adventitia. The recent interest in PVAT as an endocrine and paracrine organ has led to a number of studies investigating the characteristics of various fat depots in the body. Soltis and Cassis (1991) first described that PVAT significantly attenuated vascular responsiveness of Sprague-Dawley rat aortae to noradrenaline (Soltis and Cassis, 1991) . This result was confirmed by Lohn et al. (2002) who re-examined the idea of periadventitial vasoregulation. Their study provided additional proof that PVAT inhibited vasoconstriction induced by a number of additional agonists such as angiotensin II, 5-HT and phenylephrine (Lohn et al., 2002) . Adiponectin is a major factor secreted by adipocytes (Scherer et al., 1995) and exerts its action by binding to its receptors (Adipo1 receptor and Adipo2 receptor) (Kadowaki and Yamauchi, 2005) . Although downstream regulation of signalling of these receptors is yet to be fully identified, overexpression of adaptor protein phosphotyrosine interacting with APPL1 (PH domain and leucine zipper 1) enhances and suppression of the APPL1 level attenuates adiponectin signalling and its downstream events (Mao et al., 2006) .
Functional studies have found that adiponectin can relax murine mesenteric artery by opening K v channels (Fesus et al., 2007) and (Greenstein et al., 2009) concluded that adiponectin was the anti-contractile adipokine released from rat mesenteric arterial PVAT. Moreover, a fragment of the adiponectin receptor abolished the PVAT-induced vasorelaxation in human small arteries taken from subcutaneous gluteal fat biopsy samples, which further suggests that adiponectin is a predominant mediator of the relaxation (Greenstein et al., 2009) . Noteworthy, there are accumulating data about the potential effect of PVAT in regulating the vascular tone where PVAT could induce both vasorelaxation and vasoconstriction depending on the anatomical position, species and condition (Nava and Llorens, 2016; Verlohren et al., 2004; Yudkin et al., 2005; Owen et al., 2013; Szasz et al., 2013) .
In recent studies, we have demonstrated that there are sex differences in the regulation of tone in the porcine coronary artery (PCA) (Wong et al., 2014) . As there are also sex differences in the release of adipokines from adipose tissue in general, in this study we investigated whether there are sex differences in the regulation of vascular tone by PVAT in the PCA. Our findings demonstrate that PVAT surrounding coronary arteries from females has an anticontractile effect, which is not seen in males, indicating that PVAT may have a protective effect on coronary arteries in females, but not males.
Methods

Tissue preparation
Hearts from male and female pigs (large white hybrid pigs, 4-6 months old, weighing~50 kg) were obtained from a local abattoir and transported back to the laboratory in ice-cold modified Krebs'-Henseleit solution (118 mM NaCl, 4.8 mM KCl, 1.1 mM MgSO 4 , 25 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 12 mM D-glucose, 1.25 mM CaCl 2 ). Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Experiments were blinded as the experimenter did not know whether the tissues were from male or female animals until after the experiments had been undertaken. The anterior proximal part of the coronary artery was then dissected and placed in Krebs'-Henseleit solution pre-gassed with 5% CO 2 and 95% O 2 and kept overnight in the refrigerator. On the second day, fine dissection was performed to prepare paired PCA rings from each artery ensuring vessels were not stretched or damaged. PCAs were then cut into rings of approximately 5 mm in length and suspended in a multichannel 5 mL organ bath. Each bath was filled with 5 mL of Krebs'-Henseleit solution and maintained at 37°C and constantly gassed with carbogen (95% O 2 , 5% CO 2 ). Tension was measured and recorded using a Powerlab data acquisition system (ADInstruments) via an amplifier.
Experimental protocol
Organ bath studies. Tissues were initially pre-tensioned to 73.6 mN, determined from preliminary studies, and then left to equilibrate for approximately 30-45 min. Once a stable baseline was reached, two consecutive responses to 60 mM KCl were obtained for standardization. After about 20 min, the KCl was washed out with fresh Krebs'-Henseleit solution. Following the return to a stable baseline and, after a further 15-30 min, exposure to KCl was repeated. Once again, the tissue was washed out with Krebs'-Henseleit solution, to allow the segment tone to re-stabilize to baseline. The data were calculated and expressed as a percentage of the contraction in response to 60 mM KCl. The KCl response is considered as a reference to the viability and activity of each segment in order to avoid the individual variation in the response of the coronary artery. Thereafter, relevant test compounds were added and allowed a 60 min incubation time. The following test compounds were used: N G -nitro-L-arginine methyl ester (L-NAME; 300 μM) to inhibit NOS (Wong et al., 2014) and indomethacin (10 μM) (Malinowski et al., 2008) to inhibit COX. Pre-incubation with an antiadiponectin antibody (1:100; ABIN1857924, antibodiesonline Inc., Atlanta, GA, USA) was performed to determine the role of adiponectin in PVAT-induced vasorelaxation in females. U46619 was added cumulatively (1-300 nM) to induce contraction in the arterial rings, which was BJP A A Ahmad et al.
calculated as a percentage of the contraction in response to 60 mM KCl. In some experiments, endothelin-1 (ET-1) (1 nM-300 nM) was used as contractile agent. In other sets of experiments, PVAT (0.3 g) was added to vessels in which the PVAT had previously been removed and pre-contracted with U46619 to a level of 40-60% of the maximum KCl response. In a further set of experiments, cumulative concentration-response curves to the adiponectin receptor agonist, adipoRon (1-100 μM) (Okada-Iwabu et al., 2013), were performed in PCAs pre-contracted with U46619.
Western immunoblotting
PAGE followed by Western immunoblotting was performed to determine the expression of adiponectin levels in PVAT and the adiponectin receptors (Adipo1 receptor and Adipo2 receptor) and APPL1 in PCAs from different pigs from each sex. PVAT or PCA samples were finely dissected and homogenized on ice using Tris-EDTA buffer (pH 7.4) and protease inhibitor cocktail (Calbiochem, VWR International Ltd, Lutterworth, Leicestershire, UK). After estimation of the protein content of each sample using a Lowry protein assay, Laemmli solubilization buffer was added. Samples were then heated at 100°C for 5 min and centrifuged at 13000 × g for 1 min. PVAT (20 μg) and PCA (20 μg) samples were separated using a 4-20% gradient polyacrylamide gradient gel (Bio-Rad, Hemel Hempstead, Hertfordshire, UK) and then transferred onto a nitrocellulose membrane (GE Healthcare, Little Chalfont, Buckinghamshire, UK) by Western blotting. Porcine skeletal muscle and rat liver tissues were used as a positive control for Adipo1 receptor and Adipo2 receptor, respectively (Ding et al., 2009) . Membranes were then blocked with 5% w . v -1 non-fat milk, or 5% w . v -1 BSA in the case of APPL1, in Tris-buffered saline containing 0.1% Tween 20 (TBST) at room temperature for 1 h. The blot was then incubated with rabbit anti-adiponectin antibody (1:400 dilution; ABIN1857924, antibodies-online Inc., Atlanta, GA, USA), rabbit anti-Adipo1 receptor antibody (1:500; 250476, Abbiotec, USA), rabbit anti-Adipo2 receptor antibody (1:250 dilution; orb10047, Biorbyt, Cambridge, UK) and rabbit anti-APPL1 antibody (1:2000; mAb 3858, Cell Signalling Technology, UK) in 5% milk or in 5% BSA in the case of APPL1 antibody, in Tris-buffer overnight at 4°C. Membranes were also incubated with a mouse anti-β-actin antibody (1:50 000 in 5% milk; Sigma-Aldrich, Poole, Dorset, UK) or an antimouse myosin light chains antibody (1:1000 in 5% milk; Sigma-Aldrich) as a loading control as well as to quantify porcine proteins. On the second day, the blot was washed in TBST followed by incubation with IRDye 800CW goat anti-rabbit and IRDye 680CW goat anti-mouse secondary antibodies (both 1:10 000 dilution; IRDye, Licor, Cambridge, UK). The immunoblot was then visualized using an Odyssey system from Licor and intensity of the bands measured using Odyssey Image Studio (Licor).
Determination of adiponectin levels released from PVAT
PVAT (0.15 g) was incubated in 1 mL of Krebs'-Henseleit solution at 37°C. Adiponectin levels in the buffer were then determined using a pig adiponectin ELISA Kit (abx255420; Abbexa, Cambridge, UK) following the manufacturer's protocol. The range of standard curve is 31.25-1000 ng·mL À1 ; sensitivity: <18.75 ng·mL À1 . The intra-assay coefficient of variation was 10.1.
Data and statistical analysis
Data are expressed as mean ± SEM where n = the number of different animals. The concentration-response curves were fitted to a sigmoidal curve with a variable slope using four parameters logistic equation using GraphPad Prism software.
The maximum percentage contraction (R max ) and the negative log of concentration required to produce half the maximal contraction of the induced tone (pEC 50 ) were calculated from the fitted curves. R max and pEC 50 values were analysed using a two-tailed, paired or unpaired Student's t-test to compare differences between two groups, as appropriate. Differences between three or more groups were assessed using a one-way ANOVA or two-way ANOVA in conjunction with the Sidak's post hoc test to assess possible difference at individual concentrations. P < 0.05 was considered statistically significant. Statistical analysis was performed by GraphPad Prism (Version 6). The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) .
Materials
All drugs were purchased from Sigma-Aldrich except for ET-1, which came from Tocris Bioscience and adiponectin from Antibodies-online Inc. Stock solutions of L-NAME and adiponectin were dissolved in distilled water. Stock solution of indomethacin was dissolved in absolute ethanol. Stock solutions of U46619 were made to 10 mM in ethanol whilst DMSO was used as a solvent to make 10 mM of adipoRon. All further dilutions of the stock solutions were made using distilled water. All stocks were kept frozen at À20°C.
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www. guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 .
Results
The effects of PVATon U46619-induced vasoconstriction in PCAs from female and male pigs
In order to determine the effects of perivascular fat on vascular contraction, concentration-response curves to the thromboxane mimetic U46619 were determined in coronary artery segments from female and male pigs ( Figure 1A , B), with and without adherent PVAT. The presence of fat reduced the maximum contraction to U46619 in coronary arteries from females. There was also a rightward shift in the concentration-response curve. On the other hand, the presence of PVAT had no effect on the U46619-induced contraction in coronary arteries from male pigs ( Figure 1B) . Similarly, the ET-1-induced vasoconstriction was significantly reduced in coronary arteries from female pigs in the presence of fat with no change in pEC 50 ( Figure 1C ). Furthermore, PVAT had no effect on the ET-1-mediated vasoconstriction in PCAs from male ( Figure 1D ). There was no significant difference in the size of the contractile response to 60 mM KCl with PVAT compared with without PVAT (females, control = 8 ± 0.8 g without PVAT compared with 6.4 ± 0.6 g with PVAT; males, control = 9.4 ± 1.2 without PVAT compared with 7.7 ± 0.9 g with PVAT).
Acute effects of added PVATon rings pre-contracted with U46619
Coronary arterial segments from female pigs with fat removed were pre-contracted submaximally with U46619. Once a stable tone was obtained, 0.3 g PVAT was then added ( Figure 2C ). PVAT from female animals caused immediate relaxation (R) (Figure 2A, C) . On the other hand, PVAT from male animals had no significant effect on the U46619-induced vasoconstriction compared with time control ( Figure 2B ). Furthermore, a crossover study in which PVAT from females was added to PCAs from males showed no vasorelaxant effect ( Figure 2D ).
The effects of L-NAME and indomethacin on the anti-contractile effect of PVAT in PCAs
The maximum response of PCAs to U46619 was significantly inhibited in the presence of PVAT, as before (Figure 3) . A combination of L-NAME and indomethacin had no effect on the concentration-response curve to U46619 in the absence of PVAT, but this combination prevented the inhibitory effect of PVAT on the U46619 response ( Figure 3A, B) . On the other hand, incubation with either L-NAME or indomethacin alone had no effect on the anti-contractile response of PVAT ( Figure 3B ).
Role of adiponectin in PVAT-mediated vasorelaxation in females
Previous studies have indicated that adiponectin acts through NOS and COX-dependent ways. Therefore, we determined the role of adiponectin in the relaxation effect seen in the presence of PVAT. Segments of coronary arteries from females were pretreated with an anti-adiponectin antibody, in order to bind any released adiponectin. In the presence of the anti-adiponectin antibody, the PVAT-induced relaxation was abolished (Figure 4 ).
Adiponectin expression in PVAT
Our data indicate that PVAT from females, but not males, causes relaxation of coronary arteries through the release of adiponectin. In order to determine whether the differences in the role of PVAT in arteries from male and female animals was due to differences in the amount of adiponectin in PVAT, the expression of adiponectin in PVAT was determined by Western immunoblotting. There was no significant difference in the expression of adiponectin in coronary artery PVAT from female and male animals ( Figure 5A, B) . 
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Adiponectin release from PVAT
As there was no difference in the level of expression of adiponectin in PVAT between male and female animals, we determined whether there is a difference in the release of adiponectin from PVAT. Although adiponectin could be detected in the buffer that the PVAT was incubated in, there was no significant difference in the level of released adiponectin between PVAT from male and female animals ( Figure 5C ).
Responsiveness of porcine coronary arteries to adipoRon
As there was no difference in either the expression of adiponectin or release of adiponectin from PVAT, we determined whether there was a difference in the sensitivity to adiponectin receptor activation between male and female animals. AdipoRon, an adiponectin receptor agonist, produced a concentration-dependent relaxation of coronary arteries from both female and male pigs. However, there was a greater relaxation in arteries from female pigs compared with male (at 100 μM, females: 106 ± 8% relaxation, n = 6; males: 78 ± 6% relaxation, n = 8). AdipoRon also appeared to be more potent in arteries from females compared with males, based on the observation that adipoRon produced a relaxation at lower concentrations ( Figure 6 ).
Expression of adiponectin receptors in PCAs
To clarify the difference in the responsiveness of PCAs in different sexes, we measured the level of expression of two different isoforms of adiponectin receptors (Adipo1 receptor and Adipo2 receptor) in PCAs from both sexes, using Western immunoblotting. Numerous bands were detected with the anti-Adipo1 receptor antibody, but none lined up with the band in the rat skeletal muscle positive control at the predicted molecular weight of 40 kDa, suggesting that there is no detectable expression of Adipo1 receptor in PCAs from either females or males ( Figure 7A ). Similarly numerous bands were obtained with the anti-Adipo2 receptor antibody ( Figure 7B) . A band at the predicted molecular weight of 42 kDa lined up with a band at the same molecular weight in the rat liver positive control was taken to be Adipo2 receptor. This band was expressed in PCAs from both sexes. However, there was no apparent difference in the expression of Adipo2 receptor in PCAs from females compared with males ( Figure 7B, C) .
Expression of APPL1 in PCAs
As there was no difference in the expression of adiponectin receptors between females and males PCAs, we then investigated the expression of the adiponectin-binding protein APPL1 in PCAs by Western immunoblotting. A band for APPL1 was detected at the predicted molecular weight of 82 kDa. However, there was no significant difference in APPL1 expression between PCAs from both sexes ( Figure 7D , E).
Discussion
The recognition that PVAT is not simply a reservoir for lipid storage but is also a complex endocrine organ has led to substantial research efforts to establish the mechanistic links between the PVAT and vascular tone regulation. The majority of research in this area has been carried out on blood vessels from male animals and has concentrated mostly on murine aorta and mesenteric vessels. A few studies have determined the role of PVAT in the regulation of coronary artery tone, but this is the first study to compare the effects of PVAT from male and female animals. We have identified clear sex differences in the regulation of coronary artery tone by PVAT, with PVAT from female animals producing an anticontractile, relaxation response, which was not seen in PVAT from male animals. In the presence of fat, contractile responses to both the thromboxane receptor agonist U46619 and ET-1 were reduced in coronary arteries from female pigs, but not from male pigs, indicating the release of an anti-contractile Figure 3 Role of NOS and COX in PVAT-induced vasorelaxation. (A) Log concentration-response curves for the vasoconstrictor effects of U46619 in the absence or presence of PVAT in female PCAs with and without pre-incubation with L-NAME (300 μM) and indomethacin (10 μM). Data are expressed as a percentage of the contraction to 60 mM KCl and are mean ± SEM of 11 experiments. (B) Maximum response to the vasoconstrictor effects of U46619 in female PCAs with fat attached and either absence or presence of pre-incubation with L-NAME (300 μM) and indomethacin (10 μM). Data are expressed as a percentage of the contraction to 60 mM KCl and are mean ± SEM of six experiments. * indicates P < 0.05, one-way ANOVA v control followed by a Sidak's post hoc test vs control.
Figure 4
Role of adiponectin in PVAT-induced vasorelaxtion. Effect of preincubation with an anti-adiponectin antibody on PVAT (0.3 g)-induced vasorelaxation in female PCAs. Data are expressed as a percentage change from the U46619-induced tone and are mean ± SEM of four experiments. * indicates P < 0.05, Student's two-tailed, paired t-test.
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compound from the PVAT surrounding the coronary arteries in females. Re-addition of fat removed from the coronary arteries into the tissue baths produced a relaxation response in arteries from females, but not males. In order to confirm this finding, we performed a crossover study in which PVAT from females was added to male arteries. Although PVAT from females induced a relaxation in coronary artery from females, the PVAT from females did not produce a relaxation in coronary arteries from males. Taken together, these data suggest that the PVAT surrounding coronary arteries from female animals may have a protective, anti-contractile role, which may contribute to the reduced incidence of coronary artery disease in females.
The present results are consistent with the studies by Gao et al. (2007) and Malinowski et al. (2008) , which have shown that PVAT reduces vascular tone in the rat aorta and human internal thoracic arteries, respectively, although sex differences in these responses were not determined. In contrast, previous studies in PCA have indicated the release of a contractile agent from PVAT, although again sex differences in the responses were not examined (Owen et al., 2013) .
In mouse mesenteric arteries, the anti-contractile effect of PVAT is mediated through either NO or COX-dependent pathways (Lynch et al., 2013) . Similarly, in this study, we demonstrated that the anti-contractile effect of PVAT in coronary arteries from female pigs was sensitive to inhibition with a combination of the NOS inhibitor L-NAME and the COX inhibitor indomethacin, whereas inhibition of each enzyme separately had no significant effect. These data indicate the involvement of both NO and COX metabolites in the PVAT response. This is similar to the findings of Lynch et al. (2013) who also found that inhibition of both NOS and COX was required to inhibit the anti-contractile response. Dual inhibition is probably necessary because of compensatory activation of the other pathway. In general, this observation is in line with a previous study on aorta from Wistar rats, which found that PVAT could exert its anti-contractile effects by secreting a relaxant factor, which mediates endotheliumdependent vasorelaxation through NO release (Gao et al., 2007) . On the other hand, these findings differ from a previous study by Malinowski et al. (2008) , which was conducted on the human internal thoracic artery where they reported that blocking NOS and COX could not restore the vascular response in intact rings. In fact, these differences may reflect changes in vascular responses in cardiovascular disease as the human vessels used were from patients with severe coronary artery disease and therefore likely to have endothelial dysfunction. In addition, the inconsistency of findings for the role of NO and COX in all previous studies could probably be due to the indefinite sex used.
In order to identify the mechanism underlying the sex difference in the anti-contractile effect of PVAT in the PCA, 
Figure 6
AdipoRon-induced arterial relaxation. Log concentration-response curves to adipoRon in coronary arteries from female and male pigs. Data are expressed as a percentage change from U46619-induced tone and are mean ± SEM of six female and eight male experiments. * indicates P < 0.05 (two-way ANOVA followed by a Sidak's post hoc test).
Sex differences in PVAT-vascular coupling BJP
we investigated the role of adiponectin. Adiponectin is the most abundant adipokine in the circulation and has been shown to activate both NO and COX-dependent pathways (Tan et al., 2004; Shibata et al., 2005; Lee et al., 2010) . As there is no selective adiponectin receptor antagonist available, we used an anti-adiponectin antibody to bind any adiponectin released from the PVAT and prevent it from activating the receptor on the artery. To this end, we determined the effect of the antibody on the relaxation due to addition of PVAT, rather than using fat-attached arteries. This is because the close proximity of the fat to the blood vessel in fat-attached preparations may not allow the antibody access to bind released adiponectin. Under these conditions, the presence of the anti-adiponectin antibody completely prevented the PVAT-induced relaxation, indicating that adiponectin is likely to be the mediator released from the fat. Therefore, we investigated whether the sex differences in the relaxation were due to differences in adiponectin expression, release or function. Using Western immunoblotting, we identified the presence of adiponectin in PVAT from the coronary artery, although there was no difference between male and females. Furthermore, there was no difference in the level of adiponectin released from PVAT, indicating that the difference in the relaxation response is not due to a difference in either expression or release of adiponectin. On the other hand, using an adiponectin receptor agonist, adipoRon, we demonstrated that activation of the adiponectin receptor produces a greater relaxation and at lower concentrations in coronary arteries from females compared with males. These data indicate that the sex difference in the anti-contractile effect of PVAT is likely to be due to a difference in the responsiveness of the arteries to adiponectin. Noteworthy, responses to adiponectin receptor activation are independent of the endothelium in that denudation of the endothelium did not alter the relaxation to adipoRon in the coronary artery (Supporting Information Figure S1 ).
In an attempt to identify the reason for the differences in adiponectin response, we determined the expression of the adiponectin receptors in the coronary artery. Using Western immunoblotting, we identified expression of Adipo2 receptor but not Adipo1 receptor in PCAs from both sexes. However, there was no apparent difference in the expression of Adipo2 receptor between males and females.
Since no sex difference was identified in adiponectin receptors expression, so we investigated the expression of APPL1, which has been identified as an Adipo1 receptor and Adipo2 receptor binding protein (Buechler et al., 2010) and considered as a downstream regulator of adiponectin signalling (Mao et al., 2006; Cheng et al., 2007) . Although we have showed an expression of this adaptor protein APPL1 in PCAs, there was no significant difference between sexes. The limitation in our investigation is that the expression of different proteins studied in this research was examined in total homogenate rather than vascular smooth muscle only. In addition, total adiponectin receptors expression was measured rather than the expression of just surface receptors. As adiponectin receptors are distributed in the cytoplasm (Ding et al., 2009 ) and on the cell membrane (Yamauchi et al., 2003) , differences in either cellular or subcellular distribution could underlie the sex differences. We have previously demonstrated sex differences in intracellular signalling pathways involved in vasorelaxation. In particular, there are sex differences in the relative contribution of the NO and EDH signalling pathways in the PCA, as well as differences in the mechanisms underlying the EDH response (Wong et al., 2015a,b) . Therefore, differences in signalling may contribute to the sex differences in adiponectin relaxation seen in this study. In addition, malfunction and resistance to adiponectin have been identified in different conditions such as obesity (Bruce et al., 2005; Chen et al., 2005) , high-fat diet (Mullen et al., 2009 ) and cardiovascular diseases (Lau et al., 2011) . Therefore, we cannot exclude the possibility of adiponectin resistance in the coronary arteries from males.
Although there was reduced relaxation to AdipoRon in porcine coronary arteries from males, there was still a relaxation and not the complete absence of relaxation seen with the addition of PVAT. The lack of relaxation to PVAT in males could be because the amount of adiponectin released from PVAT is too small to induce a relaxation in males. Alternatively, other studies have indicated that an unknown contractile factor is released from PCA PVAT. This may counteract the relaxation response to adiponectin in males.
Clinical relevance of the study
It is becoming increasingly clear that PVAT plays a role in cardiovascular pathophysiology. For instance, an apparent link has been found between an increase in PVAT and coronary artery disease (Verhagen and Visseren, 2011) . In addition, several clinical studies have demonstrated vascular protective effects of adiponectin as low plasma levels of adiponectin are associated with hypertension and other cardiovascular diseases (Imatoh et al., 2008; Aprahamian and Sam, 2011; Kim et al., 2013) and high levels of adiponectin are associated with a reduced incidence of acute coronary syndrome and acute myocardial infarction (Pischon et al., 2004; Mittal et al., 2013) . The present study demonstrates that only PVAT from females has an anti-contractile effect on the coronary artery tone and thus may contribute to the reduced incidence of cardiovascular disease in pre-menopausal women. However, further studies are required to determine whether similar sex differences in the regulation of tone by PVAT are observed in other blood vessels and, importantly, whether similar effects are seen in humans.
In summary, the present study illustrates that there are clear sex differences in PVAT function, where PVAT exhibits an anti-contractile responses in PCAs from female pigs, but not male pigs, which appears to be due to increased adiponectin activity. The sex difference in the PVAT response is not explained by a difference in the expression or release of adiponectin but may be explained by a greater sensitivity of coronary arteries from females to adiponectin receptor activation. This is the first study to demonstrate that PVAT may have a protective effect on coronary arteries in females, which is not present in males. This protective effect could contribute to the cardiovascular protective effects observed in females. Future studies into the role of PVAT on vascular tone should take into account potential sex differences in the responses.
